Glare PA, Walsh TD. Dose-ranging study of oxycodone for chronic pain in advanced cancer. J Clin Oncol1993; 11: 973–978.
2.
Poyhia R, Vainio A, Kalso E. A review of oxycodone's clinical pharmacokinetics and pharmacodynamics. J Pain Symptom Manage1993; 8: 63–67.
3.
Kalso E, Vainio A. Morphine and oxycodone hydrochloride in the management of cancer pain. Clin Pharmacol Ther1990; 47: 639–646.
4.
Kalso E, Vainio A. Hallucinations during morphine but not during oxycodone treatment. Lancet1988; ii: 912.
5.
Maddocks I, Somogyi A, Abbott F, Hayball P, Parker D. Attenuation of morphine-induced delirium in palliative care by substitution with infusion of oxycodone. J Pain Symptom Manage1996; 12: 182–189.
6.
de Stoutz ND, Bruera E, Suarez-Almazor M. Opioid rotation for toxicity reduction in terminal cancer patientsJ Pain Symptom Manage1995; 10: 378–384.
7.
Galer BS, Coyle N, Pasternak GW, Portenoy RK. Individual variability in the response to different opioids: report of five cases. Pain1992; 49: 87–91.